Eczema Free Forever™

Game-changing cholesterol-buster further reduces heart attack, stroke

A new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.
Managed Healthcare Executive – Health Management

Eczema Free Forever™